Form 8-K - Current report:
SEC Accession No. 0001396814-25-000011
Filing Date
2025-01-10
Accepted
2025-01-10 08:01:45
Documents
15
Period of Report
2025-01-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K pcrx-20250110.htm   iXBRL 8-K 24941
2 EX-99.1 pcrx-2024revenuepressrelea.htm EX-99.1 39807
6 PACIRA BIOSCIENCES LOGO paciralogo2025a.jpg GRAPHIC 82257
  Complete submission text file 0001396814-25-000011.txt   313989

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcrx-20250110.xsd EX-101.SCH 1792
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcrx-20250110_lab.xml EX-101.LAB 22771
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcrx-20250110_pre.xml EX-101.PRE 13050
18 EXTRACTED XBRL INSTANCE DOCUMENT pcrx-20250110_htm.xml XML 2830
Mailing Address 5401 WEST KENNEDY BOULEVARD SUITE 890 TAMPA FL 33609
Business Address 5401 WEST KENNEDY BOULEVARD SUITE 890 TAMPA FL 33609 813-553-6680
Pacira BioSciences, Inc. (Filer) CIK: 0001396814 (see all company filings)

EIN.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35060 | Film No.: 25520509
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)